Tag: pharmaceuticals
-
Biotech Start-Up Finds STD Treatment in Anti-Cancer Therapy
Researchers with the biotechnology company TherapyX Inc. in Buffalo, New York found a potential treatment for the sexually transmitted disease (STD) gonorrhea in a therapy the company is developing for cancer. The team from TherapyX, a spin-off company of the University at Buffalo medical school, published its findings today online in the Journal of Infectious…
-
Cleveland Clinic Spin-Off Developing Breast Cancer Vaccine
Shield Biotech, a spin-off company from the Cleveland Clinic in Ohio, is creating a vaccine to prevent breast cancer based on research conducted at the clinic’s research institute. Vincent Tuohy, a Cleveland Clinic immunologist, founded the company with the clinic’s commercialization division, and serves as its chief scientist. Tuohy’s research seeks to find a method for protecting…
-
Fox Foundation, Companies Create Research Tools Group
The Michael J. Fox Foundation for Parkinson’s Research in New York and seven companies are joining in a consortium to systematize development and sharing of tools for studying Parkinson’s disease. The seven companies are Amicus Therapeutics, ApoPharma, Biogen Idec, Eli Lilly and Company, Pfizer, PsychoGenics and Upsher-Smith Laboratories. The group, called the Parkinson’s Disease Research Tools…
-
Nanodiamonds Improve Chemotherapy Targeting for Brain Tumors
Researchers at University of California in Los Angeles, with colleagues from Northwestern University and Lurie Children’s Hospital of Chicago, developed a more precise delivery method for chemotherapy drugs using nanoscale diamonds to treat brain tumors. The team that included participants from the lab of UCLA biomedical engineering professor Dean Ho published their findings online in…
-
Clinical Trial Tests Implantable Melanoma Vaccine
Engineering and medical researchers at Harvard University, with colleagues from the Dana-Farber Cancer Institute, started an early-stage clinical trial testing an implanted vaccine to treat melanoma, an aggressive form of skin cancer.The trial is designed primarily to test the safety of the proposed treatments with patients having advanced melanoma that has spread in the body,…
-
Biopharm Raises $45.9M in Venture Funding for Ear Disorders
Otonomy Inc., a biopharmaceutical company in San Diego specializing in middle and inner-ear disorders, collected $45.9 million in its third venture financing round. OrbiMed Advisors, a venture capital company specializing in health care investments, led the round with new investors Aperture Venture Partners and Osage University Partners taking part, along with current investors Avalon Ventures,…
-
Portal Launched Matching Cancer Cells to Drug Molecules
The Broad Institute, a medical research organization with scientists from Harvard University and Massachusetts Institute of Technology, opened its Cancer Therapeutics Response Portal, an online resource that matches potential drug molecules to their sensitivities among hundreds of cancer cell lines. The portal is described this week in the journal Cell (paid subscription required), in an…
-
Genetic Technique Tracks Salmonella Strain in Supply Chain
Agricultural scientists at Pennsylvania State University found a way of identifying and tracking strains of antibiotic resistant Salmonella bacteria through the food supply chain, even if the strain evolves. The team from the lab of food science professor Edward Dudley describes the technique in the September issue of the journal Antimicrobial Agents and Chemotherapy (paid…
-
University, Company Partner on Computer-Based Drug Discovery
The drug discovery company Serometrix in Pittsford, New York is deploying bioinformatics software developed by University of Strathclyde in Glasgow, Scotland for identifying protein structures that show subtle clues as potential targets for drugs. Financial terms of of the licensing agreement were not disclosed. The system is a result of a collaboration between Strathclyde chemistry…
-
Trial Testing Rose Bengal Compound as Melanoma Treatment
A new clinical trial at Moffitt Cancer Center in Tampa, Florida is testing a compound derived from rose bengal, a dye for diagnosing eye disorders, as an injectable treatment for melanoma, a form of skin cancer. The early-stage trial is conducted with Provectus Pharmaceuticals in Knoxville, Tennessee that is commercializing the compound, known as PV-10.…